[ad_1]
In an interview with "CBS This Morning: Saturday," the singer revealed that he was suffering from a rare degenerative muscle disorder called Inclusion-Body Myositis (IBM).
In an interview with CBS this morning: Saturday Peter Frampton revealed that he was suffering from a rare degenerative muscle disorder called myositis with bodily inclusions (Inclusion-Body Myositis, IBM) and that the diagnosis means that his next tour will be the last.
IBM is a progressive disease and Frampton, 68, told CBS that he wanted to play as much of the guitar as possible before it began to affect his performance ability.
"What will happen, unfortunately, is that it affects the flexors of the fingers," he said. "So, for a guitarist, it's not very good, I can play very well now, but in a year, maybe less well, I'm a perfectionist and I do not want to go and feel like "It's not good. It would be a nightmare for me."
In addition to the farewell tour, which will begin in June and continue until October 12, Frampton announced to CBS that he was working on new equipment. "Between October and two days ago, we created 33 new tracks," he said. "I just want to save as much as I can now for obvious reasons."
IBM Frampton was diagnosed three and a half years ago with a fall on stage, and while the news was devastating, he still has a positive attitude.
"I think every time in my life something devastating for my career, my family or myself," he said. "I took off, got up and changed direction."
There is currently no treatment for IBM, but Frampton is taking part in a new drug trial at Johns Hopkins. For a complete list of the dates of the farewell tour, click here.
This story first appeared on Billboard.com.
[ad_2]
Source link